What critical neuroendocrine cancer problem/question will researchers try to answer? Peptide receptor radionuclide therapy (PRRT) is a valuable treatment for neuroendocrine tumors, but most patients eventually experience disease progression and may have negative side effects. This project aims to improve the efficacy and reduce the side effects of PRRT for patients with gastroenteropancreatic neuroendocrine tumors … Continue reading Targeted delivery of DNA repair-inhibiting drugs to GEP-NETs